BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 30, 2026
Home » Money raised by biopharma: 2020 vs. 2019

Money raised by biopharma: 2020 vs. 2019

July 31, 2020
Article reprints

To read more on related topics, click on one of the words below.

BioWorld Analysis and data insight
    • Related Articles

      Money raised by biopharma: 2022 vs. 2021 vs. 2020 vs. 2019

      Money raised by biopharma: 2022 vs. 2021 vs. 2020 vs. 2019

      Money raised by biopharma: 2022 vs. 2021 vs. 2020 vs. 2019

    Popular Stories

    • Today's news in brief

      BioWorld
      BioWorld briefs for March 27, 2026.
    • Art concept for Parkinson's disease

      Emerging therapeutic strategies for Parkinson’s at ADPD 2026

      BioWorld
      Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
    • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

      Small-molecule TREM2 agonist advances to treat Alzheimer’s

      BioWorld Science
      Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
    • Vials, syringes, and pills

      With improved technologies, biomarkers, failed drugs may come into their own

      BioWorld
      At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
    • News in brief

      BioWorld Asia
      BioWorld Asia briefs for March 24, 2026
    • BioWorld
      • Today's news
      • Analysis and data insight
      • Clinical
      • Data Snapshots
      • Deals and M&A
      • Financings
      • Medical technology
      • Newco news
      • Opinion
      • Regulatory
    • BioWorld Science
      • Today's news
      • Biomarkers
      • Cancer
      • Conferences
      • Endocrine/metabolic
      • Immune
      • Infection
      • Neurology/psychiatric
      • NME Digest
      • Patents
    • BioWorld Asia
      • Today's news
      • Analysis and data insight
      • Australia
      • China
      • Clinical
      • Deals and M&A
      • Financings
      • Newco news
      • Regulatory
      • Science
    • More
      • About
      • Advertise with BioWorld
      • Archives
      • Article reprints and permissions
      • Contact us
      • Cookie policy
      • Copyright notice
      • Data methodology
      • Infographics: Dynamic digital data analysis
      • Index insights
      • Podcasts
      • Privacy policy
      • Share your news with BioWorld
      • Staff
      • Terms of use
      • Topic alerts
    Follow Us

    Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing